Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2024 04:00 ET | Source: AKAMPION

BellaSeno’s 3D-printed Resorbable Scaffold Successfully Used in Critical-Size Large Segmental Radius Bone Defect at Hannover Medical School

-- Trauma patient suffered from third degree open infected fracture of its radial shaft after injury by a bullet -- Graft vascularization was achieved by embedding vascular pedicle into the scaffold ...
October 30, 2023 05:00 ET | Source: AKAMPION

BellaSeno Presents Novel Production Workflow for Customized, 3D-Printed Bone Scaffolds

Presentation at the German Congress of Orthopaedics and Traumatology (DKOU)Treatment of large segmental bone defects with resorbable scaffoldsLeading-edge workflow for the design and manufacturing of...
July 06, 2023 04:00 ET | Source: AKAMPION

BellaSeno Granted Market Access in Europe for Custom-Made Bone and Pectus Excavatum Scaffolds

Market entry under new EU regulations for medical devicesSpearheading the commercialization of 3D-printed regenerative medicine products Leipzig, Germany, July 6, 2023 – BellaSeno GmbH, an ISO...
November 10, 2020 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics et ses partenaires, Cerhum, 3D-Side, mSKIL et IREC reçoivent un financement de 3M€ via le pôle santé de Wallonie, BioWin, pour le développement d’implants osseux personnalisés issus de l’ingénierie tissulaire

Gosselies, Belgique, le 10 Novembre 2020, 7h00 CET – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies cellulaires...
November 10, 2020 01:00 ET | Source: Bone Therapeutics SA

Bone Therapeutics and its collaborators Cerhum, 3D-Side, mSKIL and IREC awarded €3 million in funding under the framework of BioWin, the health cluster of Wallonia, to develop personalized, tissue engineered bone implants

Gosselies, Belgium, 10 November 2020, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases,...